The American Type Culture Collection (ATCC), doing business as Atcc, was awarded an indefinite delivery/indefinite quantity contract by the National Institute of Allergy and Infectious Diseases to provide in vitro assessments of antimicrobial activity. The multiple award contract has a potential value of $30 million to be delivered through January 2026 in support of the National Institutes of Health's infectious disease research programs.
Under the first delivery order valued at $2,500, Atcc will perform the required assessments at its facility in Manassas, Virginia through September 2020. As the premier global biological resource center, Atcc has extensive experience providing biological products and services to government agencies researching public health threats. This includes distributing critical reagents, processing biospecimens, and manufacturing biomaterials to support vaccine, therapeutic, and diagnostic development efforts. The contract and initial order aim to procure Atcc's laboratory testing capabilities to aid the National Institute of Allergy and Infectious Diseases' mission of understanding, treating, and preventing infectious, immunologic, and allergic diseases.
Generated 2/2/24, 9:05 AM